Why the study?
Although liver-derived chemerin dominates the circulating pool, perivascular adipose tissue-derived chemerin plays a more localized and functionally important role in vascular pathophysiology during obesity.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Should not yet change practice in obesity-associated CVD; leaves open PVAT chemerin as a therapeutic target for prospective trials.
Perivascular adipose tissue (PVAT) is a unique and metabolically active adipose tissue that is adjacent to most systemic blood vessels. Healthy PVAT exerts anticontractile and anti-inflammatory effects, contributing to vascular protection. However, during obesity, PVAT becomes proinflammatory and profibrotic, exacerbating vascular dysfunction. Chemerin, a multifunctional adipokine, has emerged as a key regulator of vascular tone, inflammation, and remodeling. Although liver-derived chemerin dominates the circulating chemerin pool, PVAT-derived chemerin plays a more localized and functionally important role in vascular pathophysiology because of its proximity to the vessel wall. This review highlights the role of PVAT-derived chemerin in vascular health, the mechanistic involvement of PVAT-derived chemerin in certain aspects of obesity-associated cardiovascular diseases, and the therapeutic potential of targeting PVAT-derived chemerin.
No takes yet. Share an insight, caveat, or question.
Man et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: